Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jennifer Eriksson, Matthias Hunger, François Bourhis, Robyn Thorén, Zoran Popmihajlov, Lynn Finelli & Yiling Jiang. (2020) Cost and utility in immunocompromised subjects who developed herpes zoster during the randomized V212 inactivated varicella-zoster vaccine (ZVIN) trial. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 613-621.
Read now
Read now
Jianbin Mao, Jeffrey T. McPheeters, Dongmu Zhang, Camilo J. Acosta & Lynn Finelli. (2018) Herpes zoster incidence and cost in patients receiving autologous hematopoietic stem-cell transplant. Current Medical Research and Opinion 34:4, pages 741-749.
Read now
Read now
Juliana L. Meyers, Shweta Madhwani, Debora Rausch, Sean D. Candrilli, Girishanthy Krishnarajah & Songkai Yan. (2017) Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States. Human Vaccines & Immunotherapeutics 13:8, pages 1861-1872.
Read now
Read now
Articles from other publishers (8)
Brandon J PattersonWilliam L HerringDesiree Van OorschotDesmond CurranJustin CarricoYuanhui ZhangBradley K AckersonKatia BruxvoortLina S SyHung-Fu Tseng. (2020) Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model. Journal of Managed Care & Specialty Pharmacy 26:12, pages 1567-1575.
Crossref
Crossref
Maria Francesca Piazza, Chiara Paganino, Daniela Amicizia, Cecilia Trucchi, Andrea Orsi, Matteo Astengo, Paolo Romairone, Simona Simonetti, Giancarlo Icardi & Filippo Ansaldi. (2020) The Unknown Health Burden of Herpes Zoster Hospitalizations: The Effect on Chronic Disease Course in Adult Patients ≥50 Years. Vaccines 8:1, pages 20.
Crossref
Crossref
Daniela Guerrero Vinsard, Dorothy Wakefield, Haleh Vaziri & Raffi Karagozian. (2019) Vaccine-Preventable Diseases in Hospitalized Patients With Inflammatory Bowel Disease: A Nationwide Cohort Analysis. Inflammatory Bowel Diseases 25:12, pages 1966-1973.
Crossref
Crossref
Elie A. Saade, David H. Canaday, H. Edward Davidson & Stefan Gravenstein. (2019) VZV-containing vaccines and hospitalization for herpes zoster: careful optimism. Aging Clinical and Experimental Research 31:9, pages 1347-1348.
Crossref
Crossref
Lisa A. ProsserRafael HarpazAngela M. RoseAcham GebremariamAngela GuoIsmael R. Ortega-SanchezFangjun ZhouKathleen Dooling. (2019) A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations. Annals of Internal Medicine 170:6, pages 380.
Crossref
Crossref
Shinichi Imafuku, Taizo Matsuki, Akiko Mizukami, Yasushi Goto, Sabrina de Souza, Céline Jégou, Veronique Bianco, Dominique Rosillon, Chie Ito, Desmond Curran & Katsiaryna Holl. (2018) Burden of Herpes Zoster in the Japanese Population with Immunocompromised/Chronic Disease Conditions: Results from a Cohort Study Claims Database from 2005–2014. Dermatology and Therapy 9:1, pages 117-133.
Crossref
Crossref
Jianbin Mao, Jeffrey T. McPheeters & Lyn Finelli. (2017) Healthcare utilization and costs among patients with herpes zoster and solid tumor malignancy on chemotherapy. Medicine 96:48, pages e8746.
Crossref
Crossref
Hiroyuki Nakamura, Akiko Mizukami, Koichi Adachi, Sean Matthews, Katsiaryna Holl, Kazuhiro Asano, Akihiro Watanabe, Riri Adachi, Mariko Kiuchi, Keiju Kobayashi, Keiko Sato, Taizo Matsuki, Toshihiko Kaise & Desmond Curran. (2017) Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan. Drugs - Real World Outcomes 4:4, pages 187-198.
Crossref
Crossref